FAST and Agile–the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin

作者
Mădălina-Gabriela Țâru,Cristian Tefas,Lidia Neamți,Iulia Minciună,Vlad Țâru,Anca Maniu,Ioana Rusu,Bobe Petrushev,Lucia Maria Procopciuc,Daniel‐Corneliu Leucuta,Bogdan Procopeț,S. Ferri,Monica Lupșor‐Platon,Horia Ştefănescu
出处
期刊:PLOS ONE [Public Library of Science]
卷期号:19 (5): e0303971-e0303971 被引量:21
标识
DOI:10.1371/journal.pone.0303971
摘要

BACKGROUND: MASLD is a prevalent chronic liver condition with substantial clinical implications. This study aimed to assess the effectiveness of three new, elastography-based, scoring systems for advanced fibrosis ≥F3 (Agile 3+), cirrhosis F4 (Agile 4), and fibrotic NASH: NASH + NAS ≥4 + F≥2 (FAST score), in a cohort of biopsy-proven NAFLD meeting MASLD criteria. Our secondary aim was to compare their diagnostic performances with those of other fibrosis prediction tools: LSM-VCTE alone, and common, easily available scores (FIB-4 or APRI). METHODS: Single-center, retrospective study, on consecutive patients with baseline laboratory tests, liver biopsy, and reliable LSM-VCTE measurements. The discrimination between tests was evaluated by analyzing the AUROCs. Dual cut-off approaches were applied to rule-out and rule-in ≥F3, F4 and fibrotic NASH. We tested previously reported cut-off values and provided our best thresholds to achieve Se ≥85%, Se ≥90%, and Sp ≥90%, Sp ≥95%. RESULTS: Among 246 patients, 113 (45.9%) were women, and 75 (30.5%) presented diabetes. Agile 3+ and Agile 4 demonstrated excellent performance in identifying ≥F3 and F4, achieving AUROCs of 0.909 and 0.968, while the FAST score yielded acceptable results in distinguishing fibrotic NASH. When compared to FIB-4 and LSM-VCTE, both Agile 3+ and Agile 4 performed better than FIB-4 and had a similar performance to LSM-VCTE, but with higher diagnostic accuracy, hence reducing the grey zone. CONCLUSION: Agile 3+ and Agile 4 are reliable, non-invasive tests for identifying advanced fibrosis or cirrhosis in MASLD patients, while FAST score demonstrates moderate performance in identifying fibrotic NASH.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿的应助被科研通管家采纳,获得10
1秒前
打打的应助被TJL采纳,获得10
1秒前
Lucas的应助被科研通管家采纳,获得10
1秒前
1秒前
初景的应助被科研通管家采纳,获得20
1秒前
Akim的应助被科研通管家采纳,获得10
1秒前
酷波er的应助被科研通管家采纳,获得10
1秒前
1秒前
1秒前
共享精神的应助被科研通管家采纳,获得10
1秒前
1秒前
斯文败类的应助被科研通管家采纳,获得10
1秒前
充电宝的应助被科研通管家采纳,获得10
2秒前
科研通AI65的应助被zxxzxx采纳,获得10
2秒前
不以发布了新的文献求助10
2秒前
2秒前
王晨发布了新的文献求助10
3秒前
3秒前
4秒前
4秒前
5秒前
wg发布了新的文献求助10
5秒前
庞mou完成签到,获得积分10
5秒前
小蘑菇的应助被阿萍采纳,获得10
5秒前
可爱的函函的应助被愤青采纳,获得10
5秒前
哈哈哈发布了新的文献求助10
6秒前
6秒前
hello完成签到,获得积分20
7秒前
小二郎的应助被ygy采纳,获得10
7秒前
8秒前
bertharen完成签到,获得积分20
8秒前
堪冷之完成签到,获得积分10
8秒前
求文献完成签到 ,获得积分10
8秒前
搞怪谷蓝发布了新的文献求助50
8秒前
9秒前
9秒前
Gulu_完成签到 ,获得积分10
9秒前
小画发布了新的文献求助10
10秒前
杨汐菥发布了新的文献求助10
10秒前
科研通AI6.3的应助被王晨采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188088
求助须知:如何正确求助?哪些是违规求助? 9575942
关于积分的说明 21844291
捐赠科研通 7785857
什么是DOI,文献DOI怎么找? 3435158
关于科研通互助平台的介绍 2559529
邀请新用户注册赠送积分活动 2482065